Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

generic medicines

  1. Home>
  2. News>
  3. generic medicines>
  4. Page 9

Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide

  • Post published:July 5, 2026
  • Post category:Knowledge

For international buyers, healthcare professionals, and procurement specialists, navigating the quality assurance landscape of generic medicines can be complex. One of the most globally recognized benchmarks for pharmaceutical quality is…

Continue Reading Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide

Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026

  • Post published:July 4, 2026
  • Post category:News

India's pharmaceutical sector has entered the second half of 2026 on a strong footing, with exports rising 6.6% year-on-year and the Nifty Pharma index hitting an all-time high in early…

Continue Reading Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026

India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026

  • Post published:July 3, 2026
  • Post category:Knowledge

India's reputation as the "Pharmacy of the World" rests on its ability to produce high-quality generic medicines at affordable prices. However, the past few years have exposed serious quality challenges…

Continue Reading India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026

India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise

  • Post published:July 2, 2026
  • Post category:News

India's pharmaceutical sector continues to strengthen its global position with a series of positive developments in mid-2026. From extending its lead over China in US FDA drug master filings to…

Continue Reading India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise
  • Go to the previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 17
  • Go to the next page

Recent Posts

  • India Pharma 2030 Export Target Cut to $90 Billion Amid Tariff and Shipping Crisis
    August 17, 2026/
    0 Comments
  • How to Verify Quality of Indian Generic Medicines: A Buyer’s Checklist
    August 16, 2026/
    0 Comments
  • CDSCO Digital Drug Platform: End-to-End Regulatory System in 18 Months
    August 15, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India Pharma 2030 Export Target Cut to $90 Billion Amid Tariff and Shipping Crisis
  • How to Verify Quality of Indian Generic Medicines: A Buyer’s Checklist
  • CDSCO Digital Drug Platform: End-to-End Regulatory System in 18 Months
  • Understanding India’s Drug Price Control: NPPA, NLEM and Generic Medicine Pricing
  • India’s CDSCO Digital Drug Platform to Fast-Track Approvals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve